Enhanced vasoconstrictor potency of the fixed combination calcipotriol plus betamethasone dipropionate in an innovative aerosol foam formulation vs. other corticosteroid psoriasis...

Autor Queille‐Roussel, C., Bang, B., Clonier, F., Lacour, J.‐P.
Vydáno v J Eur Acad Dermatol Venereol (2016)

Inherited epidermolysis bullosa and squamous cell carcinoma: a systematic review of 117 cases

Autor Montaudié, H., Chiaverini, C., Sbidian, E., Charlesworth, A., Lacour, J-P.
Vydáno v Orphanet J Rare Dis (2016)

Aeromonas hydrophila with Plasmid-Borne Class A Extended-Spectrum β-Lactamase TEM-24 and Three Chromosomal Class B, C, and D β-Lactamases, Isolated from a Patient with Necrotizing...

Autor Fosse, T., Giraud-Morin, C., Madinier, I., Mantoux, F., Lacour, J. P., Ortonne, J. P.
Vydáno 2004

Defective expression of plectin/HD1 in epidermolysis bullosa simplex with muscular dystrophy.

Autor Gache, Y, Chavanas, S, Lacour, J P, Wiche, G, Owaribe, K, Meneguzzi, G, Ortonne, J P
Vydáno 1996

Treatment outcomes with ixekizumab in patients with moderate‐to‐severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III r...

Autor Gottlieb, A.B., Lacour, J.‐P., Korman, N., Wilhelm, S., Dutronc, Y., Schacht, A., Erickson, J., Zhang, L., Mallbris, L., Gerdes, S.
Vydáno v J Eur Acad Dermatol Venereol (2016)

Catastrophic acute bilateral lower limbs necrosis associated with COVID‐19 as a likely consequence of both vasculitis and coagulopathy

Autor Del Giudice, P., Boudoumi, D., Le Guen, B., Reverte, M., Gutnecht, J., Lacour, J.P., Kraemer, J.P., Motard, A., Roa, M.
Vydáno v J Eur Acad Dermatol Venereol (2020)

A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate‐to‐severe plaque PSOriasis treated with BIOlogics in a REAL world se...

Autor Seneschal, J., Lacour, J.‐P., Bewley, A., Faurby, M., Paul, C., Pellacani, G., De Simone, C., Horne, L., Sohrt, A., Augustin, M., Hammond, E., Reich, K.
Vydáno v J Eur Acad Dermatol Venereol (2020)

Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO s...

Autor Richard, M.‐A., Lacour, J.‐P., Konstantinou, M.‐P., Ruer‐Mulard, M., Joly, P., Aractingi, S., Auquier, P., Pelvet, B., Augustin, M.L., Mahé, E., Chalmers, R.J.G.
Vydáno v J Eur Acad Dermatol Venereol (2020)

The burden of chronic spontaneous urticaria is substantial: Real‐world evidence from ASSURE‐CSU

Autor Maurer, M., Abuzakouk, M., Bérard, F., Canonica, W., Oude Elberink, H., Giménez‐Arnau, A., Grattan, C., Hollis, K., Knulst, A., Lacour, J.‐P., Lynde, C., Marsland, A., McBride, D., Nakonechna, A., Ortiz de Frutos, J., Proctor, C., Sussman, G., Sweeney, C., Tian, H., Weller, K., Wolin, D., Balp, M.‐M.
Vydáno v Allergy (2017)

Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE‐CSU

Autor Sussman, G., Abuzakouk, M., Bérard, F., Canonica, W., Oude Elberink, H., Giménez‐Arnau, A., Grattan, C., Hollis, K., Hunter, S., Knulst, A., Lacour, J.‐P., Lynde, C., Marsland, A., McBride, D., Maurer, M., Nakonechna, A., Ortiz de Frutos, J., Reynolds, M., Sweeney, C., Tian, H., Weller, K., Wolin, D., Balp, M.‐M.
Vydáno v Allergy (2018)

Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)...

Autor Wollenberg, A., Blauvelt, A., Guttman‐Yassky, E., Worm, M., Lynde, C., Lacour, J.‐P., Spelman, L., Katoh, N., Saeki, H., Poulin, Y., Lesiak, A., Kircik, L., Cho, S.H., Herranz, P., Cork, M.J., Peris, K., Steffensen, L.A., Bang, B., Kuznetsova, A., Jensen, T.N., Østerdal, M.L., Simpson, E.L.
Vydáno v Br J Dermatol (2020)